SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-059077
Filing Date
2023-03-03
Accepted
2023-03-03 08:30:57
Documents
14
Period of Report
2023-03-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d377824d8k.htm   iXBRL 8-K 30898
2 EX-99.1 d377824dex991.htm EX-99.1 8104
6 GRAPHIC g377824img001.jpg GRAPHIC 9759
  Complete submission text file 0001193125-23-059077.txt   179576

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA aadi-20230302.xsd EX-101.SCH 2840
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE aadi-20230302_lab.xml EX-101.LAB 17993
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aadi-20230302_pre.xml EX-101.PRE 11254
8 EXTRACTED XBRL INSTANCE DOCUMENT d377824d8k_htm.xml XML 3364
Mailing Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272
Business Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272 424-473-8055
Aadi Bioscience, Inc. (Filer) CIK: 0001422142 (see all company filings)

IRS No.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38560 | Film No.: 23701740
SIC: 2834 Pharmaceutical Preparations